Terms: = Pancreatic cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Treatment
10 results:
1. dnmt3a Cooperates with YAP/TAZ to Drive Gallbladder cancer Metastasis.
Xu S; Yuan Z; Jiang C; Chen W; Li Q; Chen T
Adv Sci (Weinh); 2024 Apr; 11(16):e2308531. PubMed ID: 38380551
[TBL] [Abstract] [Full Text] [Related]
2. Targeting polycomb repressor complex 2-mediated bivalent promoter epigenetic silencing of secreted frizzled-related protein 1 inhibits cholangiocarcinoma progression.
Wu G; Wang Q; Wang D; Xiong F; Liu W; Chen J; Wang B; Huang W; Wang X; Chen Y
Clin Transl Med; 2023 Dec; 13(12):e1502. PubMed ID: 38050190
[TBL] [Abstract] [Full Text] [Related]
3. Upregulation of RSPO3 via targeted promoter DNA demethylation inhibits the progression of cholangiocarcinoma.
Wu G; Wang D; Xiong F; Liu W; Wang Q; Chen J; Wang B; Chen Y
Clin Epigenetics; 2023 Nov; 15(1):177. PubMed ID: 37932819
[TBL] [Abstract] [Full Text] [Related]
4. Facility type is associated with improved perioperative and oncologic outcomes after minimally invasive surgery for pancreatic cancer.
Servin-Rojas M; Shafique N; Sell NM; Gamblin TC; Qadan M
HPB (Oxford); 2023 Aug; 25(8):933-940. PubMed ID: 37149486
[TBL] [Abstract] [Full Text] [Related]
5. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
Wang Q; Cai WZ; Wang QR; Zhu MQ; Yan LZ; Yu Y; Bao XB; Shen HJ; Yao H; Xie JD; Zhang TT; Zhang L; Xu XY; Shan Z; Liu H; Cen JN; Liu DD; Pan JL; Lu DR; Chen J; Xu Y; Zhang R; Wang Y; Xue SL; Miao M; Han Y; Tang XW; Qiu HY; Sun AN; Huang JY; Dai HP; Wu DP; Chen SN
Am J Hematol; 2023 Jan; 98(1):66-78. PubMed ID: 36219502
[TBL] [Abstract] [Full Text] [Related]
6. DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53‑deficient pancreatic cancer cells.
Jing W; Song N; Liu Y; Qu X; Hou K; Yang X; Che X
Mol Med Rep; 2018 Jan; 17(1):117-124. PubMed ID: 29115606
[TBL] [Abstract] [Full Text] [Related]
7. Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK.
Pan FP; Zhou HK; Bu HQ; Chen ZQ; Zhang H; Xu LP; Tang J; Yu QJ; Chu YQ; Pan J; Fei Y; Lin SZ; Liu DL; Chen L
Oncol Rep; 2016 Apr; 35(4):1941-9. PubMed ID: 26782786
[TBL] [Abstract] [Full Text] [Related]
8. Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression.
Gao J; Wang L; Xu J; Zheng J; Man X; Wu H; Jin J; Wang K; Xiao H; Li S; Li Z
J Exp Clin Cancer Res; 2013 Nov; 32(1):86. PubMed ID: 24423239
[TBL] [Abstract] [Full Text] [Related]
9. Silencing of BNIP3 results from promoter methylation by DNA methyltransferase 1 induced by the mitogen-activated protein kinase pathway.
An HJ; Lee H; Paik SG
Mol Cells; 2011 Jun; 31(6):579-83. PubMed ID: 21573703
[TBL] [Abstract] [Full Text] [Related]
10. Selective tumor irradiation by infusional brachytherapy in nonresectable pancreatic cancer: a phase I study.
Order SE; Siegel JA; Principato R; Zeiger LE; Johnson E; Lang P; Lustig R; Wallner PE
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1117-26. PubMed ID: 8985034
[TBL] [Abstract] [Full Text] [Related]
